Trevena
TRVN
$0.39
Share price
-2.74%
Change (1 day)
-63.21%
Change (1 year)
Categories
Market capitalization of Trevena (TRVN)
Market cap: $7.15 Million
As of June 2024 Trevena has a market cap of $7.15 Million. This makes Trevena the world's 8247th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Trevena from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $7.15 M | -34.71% |
| 2023 | $10.95 M | 10.26% |
| 2022 | $9.93 M | -89.63% |
| 2021 | $95.83 M | -72.01% |
| 2020 | $0.34 B | 332.19% |
| 2019 | $79.22 M | 123.8% |
| 2018 | $35.39 M | -64.49% |
| 2017 | $99.68 M | -67.61% |
| 2016 | $0.30 B | -42.31% |
| 2015 | $0.53 B | 127.32% |
| 2014 | $0.23 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Trevena was reported to be:
$7.15 Million
$7.15 Million
$7.15 Million
$7.15 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $164.06 B | 2,293,607.64% | 🇺🇸 USA |
 Merck MRK | $317.96 B | 4,445,160.21% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 6,315.94% | 🇺🇸 USA |
 Cytokinetics
CYTK | $5.61 B | 78,374.01% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $14.57 M | 103.82% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $35.5 M | 396.39% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 86,092.27% | 🇺🇸 USA |